A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis

Clinical trial NCT05176093 · COMPLETED

Trial details

NCT number: NCT05176093
Sponsor: Helixmith Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2021-11-14
Primary completion: 2022-12-29
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.